101 related articles for article (PubMed ID: 192447)
1. Association of the glycolipid pattern with antigenic alterations in mouse fibroblasts transformed by murine sarcoma virus.
Rosenfelder G; Young WW; Hakomori SI
Cancer Res; 1977 May; 37(5):1333-9. PubMed ID: 192447
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP-independent processes mediate Kirsten sarcoma virus-induced changes in collagen production and other properties of cultured cells.
Majmudar G; Peterkofsky B
J Cell Physiol; 1985 Jan; 122(1):113-9. PubMed ID: 2578130
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells.
Kannagi R; Stroup R; Cochran NA; Urdal DL; Young WW; Hakomori S
Cancer Res; 1983 Oct; 43(10):4997-5005. PubMed ID: 6860431
[TBL] [Abstract][Full Text] [Related]
4. The expression and localization of surface neoantigens in transformed and untransformed cultured cells infected with avian tumor viruses.
Phillips ER; Perdue JF
J Supramol Struct; 1976; 4(1):27-44. PubMed ID: 1256061
[TBL] [Abstract][Full Text] [Related]
5. A comparison of membrane glycoconjugates from mouse cells transformed by murine and primate RNA sarcoma viruses.
Fishman PH; Brady RO; Aaronson ST
Biochemistry; 1976 Jan; 15(1):201-8. PubMed ID: 174712
[TBL] [Abstract][Full Text] [Related]
6. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
Salomon DS; Zwiebel JA; Noda M; Bassin RH
J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
[TBL] [Abstract][Full Text] [Related]
7. Adhesion of Kirsten-ras+ tumor-progressing and Kirsten-ras- revertant 3T3 cells on fibronectin proteolytic fragments.
Radinsky R; Flickinger KS; Kosir MA; Zardi L; Culp LA
Cancer Res; 1990 Jul; 50(14):4388-400. PubMed ID: 2163749
[TBL] [Abstract][Full Text] [Related]
8. Pericellular matrix and cell surface glycoproteins of virus-transformed mouse epithelial cells.
Keski-Oja J; Gahmberg CG; Alitalo K
Cancer Res; 1982 Mar; 42(3):1147-53. PubMed ID: 6277476
[TBL] [Abstract][Full Text] [Related]
9. Phenotypically distinct target cells for murine sarcoma virus and murine leukemia virus marrow transformation in vitro.
Greenberger JS
J Natl Cancer Inst; 1979 Feb; 62(2):337-48. PubMed ID: 216835
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the characteristics of sugar uptake by mouse cells transformed by murine sarcoma viruses.
Hatanaka M; Huebner RJ; Gilden RV
J Natl Cancer Inst; 1969 Nov; 43(5):1091-6. PubMed ID: 4312003
[No Abstract] [Full Text] [Related]
11. Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibody.
Dubey DP; Staunton DE; Parekh AC; Schwarting GA; Antoniou D; Lazarus H; Yunis EJ
J Natl Cancer Inst; 1987 Feb; 78(2):203-12. PubMed ID: 3543453
[TBL] [Abstract][Full Text] [Related]
12. Identification of transformation-related antigen by monoclonal antibody on Swiss 3T3 cells induced by transfection with murine cultured colon 36 tumor DNA.
Sato N; Sato T; Takahashi S; Okubo M; Yagihashi A; Koshiba H; Kikuchi K
J Natl Cancer Inst; 1987 Feb; 78(2):307-13. PubMed ID: 3468294
[TBL] [Abstract][Full Text] [Related]
13. Radiation induction of endogenous type C virus from mouse cells transformed in vitro by murine sarcoma virus.
Niwa O; Sugahara T
J Natl Cancer Inst; 1979 Feb; 62(2):329-35. PubMed ID: 216834
[TBL] [Abstract][Full Text] [Related]
14. Glycosphingolipids of metastatic variant RNA virus-transformed nonproducer Balb/3T3 cell lines: altered metabolism and cell surface exposure.
Yogeeswaran G; Stein BS
J Natl Cancer Inst; 1980 Nov; 65(5):967-75. PubMed ID: 6253709
[No Abstract] [Full Text] [Related]
15. Augmented immunogenicity of tumor cell membranes produced by infection with influenza virus as compared to Moloney sarcoma virus.
Takeichi N; Austin FC; Oikawa T; Boone CW
Cancer Res; 1978 Dec; 38(12):4580-4. PubMed ID: 214226
[TBL] [Abstract][Full Text] [Related]
16. Surface antigens of mammalian sarcoma virus-transformed nonproducer cells.
Aoki T; Stephenson JR; Aaronson SA; Hsu KC
Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3445-9. PubMed ID: 4139711
[TBL] [Abstract][Full Text] [Related]
17. Revertants of mouse cells transformed by murine sarcoma virus: flat variants without a rescuable sarcoma virus from a clone of BALB/3T3 transformed by Kirsten MSV.
Nomura S; Dunn KJ; Mattern CF; Hartley JW; Fischinger PJ
J Gen Virol; 1974 Nov; 25(2):207-18. PubMed ID: 4140213
[No Abstract] [Full Text] [Related]
18. Multinucleation in the presence of cytochalasin B by RNA tumor virus-transformed cells.
Somers KD; Murphey MM
Cancer Res; 1980 Dec; 40(12):4410-4. PubMed ID: 6254645
[TBL] [Abstract][Full Text] [Related]
19. Growth of murine sarcoma and murine xenotropic leukemia viruses in Japanese quail: induction of tumors and development of continuous tumor cell lines.
Robey WG; Kuenzel WJ; Vande Woude GF; Fischinger PJ
Cancer Res; 1982 Jul; 42(7):2523-9. PubMed ID: 6282443
[TBL] [Abstract][Full Text] [Related]
20. Had-1, a uridine 5'-diphosphogalactose transport-defective mutant of mouse mammary tumor cell FM3A: composition of glycolipids, cell growth inhibition by lactosylceramide, and loss of tumorigenicity.
Taki T; Ogura K; Rokukawa C; Hara T; Kawakita M; Endo T; Kobata A; Handa S
Cancer Res; 1991 Mar; 51(6):1701-7. PubMed ID: 1998961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
